InvAscent invested INR 1,400 million in SRV Hospitals to expand its multi-specialty tertiary care network in India.
Information on the Target
SRV Hospitals, founded in 2015, has developed into a robust network comprising five multi-specialty hospitals in key cities including Mumbai, Nashik, and Bengaluru. With a total capacity of 500 beds, SRV Hospitals provides comprehensive tertiary care and has established itself as a leader in high-acuity healthcare services. The organization is renowned for its clinician-first approach, prioritizing patient trust and empathy in every aspect of care.
The recent investment of INR 1,400 million from InvAscent, facilitated through the India Life Sciences Fund IV, aims to augment SRV's multi-specialty tertiary care network. This funding will be directed towards enhancing critical care capabilities and acquiring advanced medical technologies, all in line with SRV's mission to make quality healthcare more accessible at the neighborhood level.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in India
The healthcare sector in India is experiencing rapid transformation, driven by increasing demand for quality medical services and technological advancements. India's healthcare system is characterized by a mix of public and private providers, with priv
Similar Deals
InvAscent → Apex Hospitals Private Limited
2025
InvAscent → Geri Care Health Services
2025
Verlinvest → The Eye Foundation
2025
GIC → Asia Healthcare Holdings
2024
TA Associates → Synokem Pharmaceuticals Ltd.
2023
InvAscent
invested in
SRV Hospitals
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $17M